Calibration of balances and pipettes for DBCMS.

The contract involves the calibration of balances and pipettes for the Division of Biochemical and Clinical Measurement Services (DBCMS) under the Food and Drug Administration (FDA). Scheduled as a forecast opportunity posted on March 11, 2026, the contract focuses on ensuring the accurate functioning of laboratory equipment crucial for maintaining measurement precision in FDA operations. The service falls under the NAICS code 811219, which pertains to equipment repair and maintenance, emphasizing the technical and specialized nature of the task. The place of performance details are unspecified, indicating potential flexibility or pending determination. Key contacts include the CDRH Acquisition Liaison, who can be reached via email, while the contracting officer has yet to be designated. This contract represents an essential part of the FDA’s quality assurance processes, supporting reliable and consistent laboratory measurements through expert calibration services.